Velocity Clinical Research

Seattle, Washington 98105

1 studies enrolling now · 2 studies all time

What they study most

Obesity or Overweight, Primary Biliary Cholangitis

Studies at this site

• A Study Observing Everyday Effectiveness and Safety of the Drug Elafibranor in Participants With Primary Biliary Cholangitis Who Are Receiving Ongoing Treatment — Recruiting now
• Study of Once-Daily Oral RGT001-075 Compared With Placebo in Adults With Obesity or Are Overweight With Weight-Related Health Conditions — Completed